GPT and metabolic syndrome: NAFLD is associated with metabolic syndrome and changes in biomarkers such as increased insulin resistance, hypertension, hyperlipidemia, elevated oxidative stress and increased plasma fibrinogen, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels [16].